Catalyst Wire Dossier Catalyst Wire Dossier

Velcaflagida

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Velcaflagida, covering 2013-02-28 to 2013-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia [Phase 1, Phase 2]

See pricing